These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1387331

  • 1. Atrial natriuretic peptide and fludrocortisone therapy in congenital adrenal hyperplasia.
    Arisaka O, Hosaka A, Arisaka M, Shimura N, Nakayama Y, Yamashiro Y, Yabuta K.
    Acta Paediatr; 1992 Mar; 81(3):268-9. PubMed ID: 1387331
    [No Abstract] [Full Text] [Related]

  • 2. Plasma renin activity in the management of congenital adrenal hyperplasia.
    Griffiths KD, Anderson JM, Rudd BT, Virdi NK, Holder G, Rayner PH.
    Arch Dis Child; 1984 Apr; 59(4):360-5. PubMed ID: 6372706
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
    Winter JS, Couch RM.
    Ann N Y Acad Sci; 1985 Apr; 458():165-73. PubMed ID: 3879120
    [No Abstract] [Full Text] [Related]

  • 5. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC, Hughes IA.
    Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
    [Abstract] [Full Text] [Related]

  • 8. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
    Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
    Horm Res Paediatr; 2018 Apr; 89(1):7-12. PubMed ID: 29073619
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
    Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3535-9. PubMed ID: 8855797
    [Abstract] [Full Text] [Related]

  • 11. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I, Cutler GB.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
    Mooij CF, Kapusta L, Otten BJ, Claahsen-van der Grinten HL.
    Horm Res Paediatr; 2010 Sep; 74(5):328-32. PubMed ID: 20357427
    [Abstract] [Full Text] [Related]

  • 13. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
    Vavrinec J, Dvorák P, Zizkovský V, Kopecký A, Pospísilová D, Starý J.
    Cesk Pediatr; 1983 Sep; 38(9):533-6. PubMed ID: 6315246
    [No Abstract] [Full Text] [Related]

  • 14. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR, Kelnar CJ, Wallace AM.
    J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
    [Abstract] [Full Text] [Related]

  • 15. Management of congenital adrenal hyperplasia.
    Antony G.
    Lancet; 1984 May 12; 1(8385):1073. PubMed ID: 6143998
    [No Abstract] [Full Text] [Related]

  • 16. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.
    Merke DP, Cho D, Calis KA, Keil MF, Chrousos GP.
    J Clin Endocrinol Metab; 2001 Jan 12; 86(1):441-5. PubMed ID: 11232038
    [Abstract] [Full Text] [Related]

  • 17. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.
    Hughes IA, Dyas J, Robinson J, Walker RF, Fahmy DR.
    Ann N Y Acad Sci; 1985 Jan 12; 458():193-202. PubMed ID: 3879122
    [No Abstract] [Full Text] [Related]

  • 18. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug 12; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 19. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 20. Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules.
    Silva IN, Oliveira-Júnior DF, Simal CJ, Viana MB, Chagas AJ.
    Indian J Pediatr; 1994 Dec 09; 61(4):341-6. PubMed ID: 8002061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.